These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9136797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H.
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [Abstract] [Full Text] [Related]

  • 3. [Nonsurgical treatment of hepatocellular carcinoma].
    Raoul JL, Boucher E, Kerbrat P.
    Bull Cancer; 1999 Jun; 86(6):537-43. PubMed ID: 10417427
    [Abstract] [Full Text] [Related]

  • 4. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 5. Current management of hepatocellular carcinoma.
    Zhou XD, Tang ZY, Yu YQ, Hou Z.
    Hepatogastroenterology; 1991 Dec; 38 Suppl 1():46-55. PubMed ID: 1668377
    [Abstract] [Full Text] [Related]

  • 6. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]

  • 9. [Strategy for the treatment of hepatocellular carcinoma].
    Suenaga M, Sugiura H, Kokuba Y, Kurumiya T, Yamanaka H, Hatsuno T, Nobuta T.
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):45-51. PubMed ID: 7826077
    [Abstract] [Full Text] [Related]

  • 10. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM.
    Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
    [Abstract] [Full Text] [Related]

  • 11. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

  • 12. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S, Watanabe Y, Ohishi H, Kono S, Nakamura M, Kubota N, Iwai S.
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [Abstract] [Full Text] [Related]

  • 13. Treatment options for hepatocellular carcinoma.
    Sandhu DS, Tharayil VS, Lai JP, Roberts LR.
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 15. [Hepatocellular carcinoma: npn-surgical treatment].
    Allgaier HP, Deibert P, Becker G, Blum HE.
    Praxis (Bern 1994); 1998 Oct 28; 87(44):1466-70. PubMed ID: 9847686
    [Abstract] [Full Text] [Related]

  • 16. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP, Rossi S, Deibert P, Zuber I, Hering M, Blum HE.
    Praxis (Bern 1994); 2000 Jun 15; 89(24):1056-60. PubMed ID: 10902462
    [Abstract] [Full Text] [Related]

  • 17. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
    Georgiades CS, Hong K, Geschwind JF.
    Cancer J; 2008 Jun 15; 14(2):117-22. PubMed ID: 18391617
    [Abstract] [Full Text] [Related]

  • 18. Treatment of nonresectable hepatocellular carcinoma: review of the literature and meta-analysis.
    Malaguarnera M, Trovato G, Restuccia S, Giugno I, Franzé CM, Receputo G, Siciliano R, Motta M, Trovato BA.
    Adv Ther; 1994 Jun 15; 11(6):303-19. PubMed ID: 10150270
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH, Chen LH.
    Ai Zheng; 2004 Jul 15; 23(7):825-8. PubMed ID: 15248921
    [Abstract] [Full Text] [Related]

  • 20. Transcatheter arterial embolization and extrabeam radiation therapy for subcutaneous seeding of hepatocellular carcinoma by percutaneous ethanol injection.
    Yamanaka T, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Takase K, Nakano T.
    Hepatogastroenterology; 2002 Jul 15; 49(48):1656-8. PubMed ID: 12397757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.